Light-activated photodynamic compounds from Theralase destroy E. coli bacteria

Sept. 15, 2011
Toronto, ON, Canada--Theralase Technologies' Photo Dynamic Compounds can destroy Escherichia coli, commonly known as the disease-causing bacteria E. coli.

Toronto, ON, Canada--After its announcement late last year that its photodynamic compounds work with light to destroy listeria bacteria, Theralase Technologies just reported that those compounds can also destroyEscherichia coli, commonly known as E. coli, a widely prevalent disease causing bacteria. Theralase, who designs, develops, manufactures, and markets patented superpulsed laser technology utilized in biostimulation and biodestruction applications, says its patented Photo Dynamic Compounds (PDCs) can be activated with light to destroy a host of harmful bacteria in clinical settings.

E. coli is one of the top four pathogens causing Healthcare Associated Infections (HAIs), and the U.S. Centers for Disease Control and Prevention estimates that HAIs have led to $45 billion in healthcare costs annually and have resulted in nearly 100,000 deaths per year, making HAIs the fourth leading cause of death.

Arkady Mandel, chief scientific officer at Theralase, said, "Our research has repeatedly demonstrated that our Photo Dynamic Therapy (PDT) destruction of E. coli bacteria is effective and represents a significant opportunity in the area of disinfection and sterilization of bacterial pathogens that may cause serious and potentially life-threatening illness."

Roger Dumoulin-White, president and CEO of Theralase, added, "We are encouraged that our patented Photo Dynamic Compounds (PDCs) are proving effective in so many varied applications. Not only are these PDCs being shown to be effective in the destruction of cancer cells, but now they are also being shown to be effective in the destruction of various types of bacteria, including Listeria and E. coli. Commercialization of these technologies becomes more and more apparent, as our research and development progresses, allowing us the opportunity to introduce these technologies to the world in a variety of diverse applications."

SOURCE: Theralase; www.theralase.com/press/Theralase_Achieves_Success_in_Destruction_of_E__Coli_4.pdf

Posted by:Gail OvertonSubscribe now to Laser Focus World magazine; It’s free! Follow us on Twitter Follow OptoIQ on your iPhone. Download the free App here

Sponsored Recommendations

Brain Computer Interface (BCI) electrode manufacturing

Jan. 31, 2025
Learn how an industry-leading Brain Computer Interface Electrode (BCI) manufacturer used precision laser micromachining to produce high-density neural microelectrode arrays.

Electro-Optic Sensor and System Performance Verification with Motion Systems

Jan. 31, 2025
To learn how to use motion control equipment for electro-optic sensor testing, click here to read our whitepaper!

How nanopositioning helped achieve fusion ignition

Jan. 31, 2025
In December 2022, the Lawrence Livermore National Laboratory's National Ignition Facility (NIF) achieved fusion ignition. Learn how Aerotech nanopositioning contributed to this...

Nanometer Scale Industrial Automation for Optical Device Manufacturing

Jan. 31, 2025
In optical device manufacturing, choosing automation technologies at the R&D level that are also suitable for production environments is critical to bringing new devices to market...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!